RT
Relation Therapeutics Inc.
SEC filingBiotechnology · Miami Beach, FL
Amount raised$36.2Msold at filing
Total offering$36.2M
Investors in the raise5count reported to the SEC
FiledDec 9, 2025first sale Nov 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David RoblinExecutive Officer, Director
Charles RobertsDirector
Jason Benjamin PontinDirector
Jim Benjamin MellonDirector
Christine Benjamin AylwardDirector
Casey Benjamin SwernerExecutive Officer
Executive officers, directors and promoters as listed on the Form D.